Education And Research

The paper is titled “C-Abl Inhibitor Imatinib Enhances Insulin Production by β Cells: C-Abl Negatively Regulates Insulin Production via Interfering with the Expression of NKx2.2 and GLUT-2.”…

Researchers found that regardless of donor pathology, outgrowth cultures produce pancreatic stellate cells that demonstrate consistent growth and protein secretion properties.

The University of Florida/Lake County Extension Office will put on “Small Steps/Big Rewards,” a four-part series about preventing and delaying diabetes.

As a long-time diabetes advocate, Janet Silverstein, M.D., has been traveling to Camp Winona in the Ocala National Forest to serve as medical director for the Florida Camp for Children and Youth with Diabetes since 1979.

Diabetes investigators at UF Health are seeking participants for a pharmaceutical research study of 1 and up to 3 years to test an investigational new drug for the treatment of Type 1 diabetes. We are looking for males and females between the ages of 18 and 35 who have been diagnosed with Type 1 diabetes within the past 8 weeks. Enrolled participants will receive payment compensation for their time and travel during the study. Learn more.

In an article published on WebMD, pediatricians argue parents may be wasting their money by buying organic foods based on the belief they are more nutritious. Dr. Janet Silverstein, a Pediatrician at the University of Florida and avid Florida Diabetes Camp supporter, gives her advice as well. The American Academy of Pediatricians provides information on milk, organic produce, and meat correlating to their research.

Patrick Rowe, PhD, a researcher at the UF Diabetes Center of Excellence, is using groundbreaking technology to better understand the early stages of type 1 diabetes. Via a laser microdissection system, he is investigating whether islet autoantibodies, early markers of risk for type 1 diabetes, are associated with stressed/overworked insulin-producing beta cells of the pancreas.

Did you hear the great news about the first artificial pancreas outpatient trial in the U.S. being approved by the FDA? To help ensure that progress like the artificial pancreas continues to improve the lives of those with diabetes by simply sending an email to your members of Congress.

University of Florida doctoral candidates and research fellows will present type 1 diabetes research findings during the 30th Annual Pediatric Science Days on March 8, 2012.

A recent study of 182 type 1 diabetes patients revealed that 10% of those who had the disease for 31 to 40 years still produced C-peptide and showed intact beta-cell functioning, suggesting insulin production may continue for decades after the disease's onset.